- Home
- LC vs DYN Comparison
LC vs DYN Comparison
Compare LC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LC
- DYN
- Stock Information
- Founded
- LC 2006
- DYN 1984
- Country
- LC United States
- DYN United States
- Employees
- LC N/A
- DYN N/A
- Industry
- LC Finance: Consumer Services
- DYN Medicinal Chemicals and Botanical Products
- Sector
- LC Finance
- DYN Health Care
- Exchange
- LC Nasdaq
- DYN Nasdaq
- Market Cap
- LC 1.7B
- DYN 1.9B
- IPO Year
- LC 2014
- DYN 2020
- Fundamental
- Price
- LC $16.69
- DYN $13.15
- Analyst Decision
- LC Buy
- DYN Strong Buy
- Analyst Count
- LC 6
- DYN 14
- Target Price
- LC $16.83
- DYN $34.93
- AVG Volume (30 Days)
- LC 1.4M
- DYN 2.3M
- Earning Date
- LC 10-22-2025
- DYN 11-11-2025
- Dividend Yield
- LC N/A
- DYN N/A
- EPS Growth
- LC 68.10
- DYN N/A
- EPS
- LC 0.64
- DYN N/A
- Revenue
- LC $1,248,526,000.00
- DYN N/A
- Revenue This Year
- LC N/A
- DYN N/A
- Revenue Next Year
- LC $15.87
- DYN N/A
- P/E Ratio
- LC $26.01
- DYN N/A
- Revenue Growth
- LC 15.90
- DYN N/A
- 52 Week Low
- LC $7.90
- DYN $6.36
- 52 Week High
- LC $18.75
- DYN $37.08
- Technical
- Relative Strength Index (RSI)
- LC 60.23
- DYN 57.48
- Support Level
- LC $16.17
- DYN $12.62
- Resistance Level
- LC $16.99
- DYN $14.35
- Average True Range (ATR)
- LC 0.48
- DYN 0.68
- MACD
- LC -0.11
- DYN -0.13
- Stochastic Oscillator
- LC 41.24
- DYN 30.72
About LC LendingClub Corporation
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.